Prognostic Impact of Active Mechanical Circulatory Support in Cardiogenic Shock Complicating Acute Myocardial Infarction, Results from the Culprit-Shock Trial
暂无分享,去创建一个
H. Thiele | M. Noc | K. Huber | J. Stȩpińska | S. Schneider | U. Zeymer | I. Eitel | S. Desch | H. Feistritzer | S. de Waha‐Thiele | A. Freund | T. Ouarrak | G. Fuernau | J. Poess
[1] H. Thiele,et al. Frequency and Impact of Bleeding on Outcome in Patients With Cardiogenic Shock. , 2020, JACC. Cardiovascular interventions.
[2] J. Messenger,et al. Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock. , 2020, JAMA.
[3] J. Henriques,et al. Mechanical circulatory support in cardiogenic shock from acute myocardial infarction: Impella CP/5.0 versus ECMO , 2020, European heart journal. Acute cardiovascular care.
[4] J. Spertus,et al. The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support , 2019, Circulation.
[5] C. Granger,et al. Clinical Practice Patterns in Temporary Mechanical Circulatory Support for Shock in the Critical Care Cardiology Trials Network (CCCTN) Registry. , 2019, Circulation. Heart failure.
[6] E. Ohman,et al. Management of cardiogenic shock complicating myocardial infarction: an update 2019. , 2019, European heart journal.
[7] C. Hassager,et al. Temporal trends in incidence and patient characteristics in cardiogenic shock following acute myocardial infarction from 2010 to 2017: a Danish cohort study , 2019, European journal of heart failure.
[8] A. Boulesteix,et al. Extracorporeal Life Support in Cardiogenic Shock Complicating Acute Myocardial Infarction. , 2019, Journal of the American College of Cardiology.
[9] B. Pieske,et al. Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock , 2019, Open Heart.
[10] F. Eberli,et al. Twenty-Year Trends in the Incidence and Outcome of Cardiogenic Shock in AMIS Plus Registry , 2019, Circulation. Cardiovascular interventions.
[11] S. Blankenberg,et al. Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock: Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis , 2019, Circulation.
[12] A. Kirtane,et al. Left Ventricular Unloading During Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock. , 2019, Journal of the American College of Cardiology.
[13] R. Yeh,et al. Hospital Variation in the Utilization of Short-Term Nondurable Mechanical Circulatory Support in Myocardial Infarction Complicated by Cardiogenic Shock , 2019, Circulation. Cardiovascular interventions.
[14] H. Thiele,et al. Intraaortic Balloon Pump in Cardiogenic Shock Complicating Acute Myocardial Infarction: Long-Term 6-Year Outcome of the Randomized IABP-SHOCK II Trial , 2019, Circulation.
[15] S. Blankenberg,et al. Venoarterial Extracorporeal Membrane Oxygenation for Cardiopulmonary Support. , 2018, Circulation.
[16] H. Thiele,et al. One‐Year Outcomes after PCI Strategies in Cardiogenic Shock , 2018, The New England journal of medicine.
[17] T. Friede,et al. Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial , 2018, European heart journal.
[18] Ajay K. Jain,et al. Contemporary trends in cardiogenic shock: Incidence, intra-aortic balloon pump utilisation and outcomes from the London Heart Attack Group , 2018, European heart journal. Acute cardiovascular care.
[19] R. Yeh,et al. National trends, predictors of use, and in-hospital outcomes in mechanical circulatory support for cardiogenic shock. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[20] J. Wald,et al. Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States , 2018, Clinical Research in Cardiology.
[21] H. Thiele,et al. Percutaneous short-term active mechanical support devices in cardiogenic shock: a systematic review and collaborative meta-analysis of randomized trials , 2017, European heart journal.
[22] H. Thiele,et al. PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock , 2017, The New England journal of medicine.
[23] J. Tijssen,et al. Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction. , 2017, Journal of the American College of Cardiology.
[24] B. D. de Mol,et al. Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis , 2016, Intensive Care Medicine.
[25] D. Brodie,et al. Extracorporeal membrane oxygenation: evolving epidemiology and mortality , 2016, Intensive Care Medicine.
[26] G. Schuler,et al. Multivessel versus culprit lesion only percutaneous revascularization plus potential staged revascularization in patients with acute myocardial infarction complicated by cardiogenic shock: Design and rationale of CULPRIT-SHOCK trial. , 2016, American heart journal.
[27] J. Messenger,et al. Use of Mechanical Circulatory Support in Patients Undergoing Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry , 2015, Circulation.
[28] A. Zaman,et al. Shock-index as a novel predictor of long-term outcome following primary percutaneous coronary intervention , 2015, European heart journal. Acute cardiovascular care.
[29] Xin Lu,et al. Trends in the use of percutaneous ventricular assist devices: analysis of national inpatient sample data, 2007 through 2012. , 2015, JAMA internal medicine.
[30] G. Schuler,et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial , 2013, The Lancet.
[31] G. Schuler,et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. , 2012, The New England journal of medicine.
[32] N. Danchin,et al. Improved outcome of cardiogenic shock at the acute stage of myocardial infarction: a report from the USIK 1995, USIC 2000, and FAST-MI French nationwide registries. , 2012, European heart journal.
[33] Kenichi A. Tanaka,et al. High mortality associated with intracardiac and intrapulmonary thromboses after cardiopulmonary bypass , 2012, Journal of Anesthesia.
[34] J. Moses,et al. Impella LP 2.5 for Left Ventricular Unloading During Venoarterial Extracorporeal Membrane Oxygenation Support , 2011, Journal of cardiac surgery.
[35] A. Barbone,et al. Left ventricle unloading by percutaneous pigtail during extracorporeal membrane oxygenation. , 2011, Interactive cardiovascular and thoracic surgery.
[36] Marco Valgimigli,et al. Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research Consortium , 2011, Circulation.
[37] Adnan Kastrati,et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. , 2008, Journal of the American College of Cardiology.
[38] M. Pfisterer,et al. Ten-Year Trends in the Incidence and Treatment of Cardiogenic Shock , 2008, Annals of Internal Medicine.
[39] D. Burkhoff,et al. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. , 2006, American heart journal.
[40] H. White,et al. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. , 2006, JAMA.
[41] G. Schuler,et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. , 2003, European heart journal.
[42] H. White,et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. , 1999, The New England journal of medicine.